Using Proteomics Data to Identify Personalized Treatments in Multiple Myeloma: A Machine Learning Approach
This paper describes a machine learning (ML) decision support system to provide a list of chemotherapeutics that individual multiple myeloma (MM) patients are sensitive/resistant to, based on their proteomic profile. The methodology used in this study involved understanding the parameter space and s...
Main Authors: | Angeliki Katsenou, Roisin O’Farrell, Paul Dowling, Caroline A. Heckman, Peter O’Gorman, Despina Bazou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/21/15570 |
Similar Items
-
Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures
by: Katie Dunphy, et al.
Published: (2023-07-01) -
Clinical Proteomics of Biofluids in Haematological Malignancies
by: Katie Dunphy, et al.
Published: (2021-07-01) -
Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
by: Paul Dowling, et al.
Published: (2021-10-01) -
Multiple Myeloma Derived Extracellular Vesicle Uptake by Monocyte Cells Stimulates IL-6 and MMP-9 Secretion and Promotes Cancer Cell Migration and Proliferation
by: Rebecca Sheridan, et al.
Published: (2024-02-01) -
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
by: Nor Hayati Ismail, et al.
Published: (2023-07-01)